Revelation Biosciences, Inc. (REVB) financial statements (2022 and earlier)

Company profile

Business Address 5 WEST 21ST STREET
NEW YORK, NY 10010
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 537
Cash and cash equivalents 12
Short-term investments 525
Prepaid expense 114
Total current assets: 651
Noncurrent Assets
Assets held-in-trust 73,511
Total noncurrent assets: 73,511
TOTAL ASSETS: 74,162
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 34
Accrued liabilities 34
Derivative instruments and hedges, liabilities 3,400
Total current liabilities: 3,434
Noncurrent Liabilities
Liabilities, other than long-term debt 2,911
Deferred revenue 2,911
Total noncurrent liabilities: 2,911
Total liabilities: 6,345
Temporary equity, carrying amount 73,509
Stockholders' equity
Stockholders' equity attributable to parent (5,692)
Common stock 2
Accumulated deficit (5,694)
Total stockholders' equity: (5,692)
TOTAL LIABILITIES AND EQUITY: 74,162

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
Operating expenses (145)
Operating loss: (145)
Nonoperating expense
(Other Nonoperating expense)
 (1,485)
Net loss available to common stockholders, diluted: (1,631)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
Net loss: (1,631)
Comprehensive loss, net of tax, attributable to parent: (1,631)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: